Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects

Novartis Investigative Site, Taoyuan District

Novartis Investigative Site, Saida

Novartis Investigative Site, Tainan City

Novartis Investigative Site, Quezon

Novartis Investigative Site, Makati City

Novartis Investigative Site, San Juan City

Novartis Investigative Site, City of Taguig

Novartis Investigative Site, Westmead

Novartis Investigative Site, Melbourne

Novartis Investigative Site, Drammen

Novartis Investigative Site, Basel

Novartis Investigative Site, Wooloongabba

Novartis Investigative Site, Salzburg

Novartis Investigative Site, Murdoch

Novartis Investigative Site, Ankara

Novartis Investigative Site, Herning

Novartis Investigative Site, Veszprém

Novartis Investigative Site, Taipei

Novartis Investigative Site, Orbassano

Novartis Investigative Site, Bangkok

Novartis Investigative Site, Bangkok

Novartis Investigative Site, Gyeonggi-do

Novartis Investigative Site, Bangkok

Novartis Investigative Site, Taipei

Novartis Investigative Site, Berlin

Novartis Investigative Site, Marseille

Novartis Investigative Site, Genova

Novartis Investigative Site, Granada

Novartis Investigative Site, Donostia / San Sebastian

Novartis Investigative Site, Rozzano

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Edirne

Novartis Investigative Site, Kuantan

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Málaga

Advent Health Cancer Institute, Orlando

Novartis Investigative Site, Montpellier

Novartis Investigative Site, Istanbul

Novartis Investigative Site, Las Palmas de Gran Canaria

Novartis Investigative Site, Padua

Novartis Investigative Site, Göttingen

Novartis Investigative Site, Khon Kaen

Novartis Investigative Site, Modena

Novartis Investigative Site, Parma

Novartis Investigative Site, Nantes

Novartis Investigative Site, Essen

Novartis Investigative Site, Valencia

Novartis Investigative Site, Georgsmarienhütte

Novartis Investigative Site, Zaragoza

Novartis Investigative Site, Kuala Lumpur

Novartis Investigative Site, Cologne

Novartis Investigative Site, Cologne

Novartis Investigative Site, Kuala Lumpur

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Lyon

Novartis Investigative Site, Gerlingen

Novartis Investigative Site, Paris

Novartis Investigative Site, Munich

Novartis Investigative Site, Avellino

Novartis Investigative Site, Kaohsiung City

Novartis Investigative Site, Bratislava

USC Kenneth Norris Comprehensive Cancer Center, Los Angeles

Novartis Investigative Site, Songkhla

Pacific Shores Medical Group, Long Beach

Novartis Investigative Site, Kuching

Novartis Investigative Site, Hanoi

Novartis Investigative Site, Beijing

Novartis Investigative Site, Singapore

Novartis Investigative Site, Changchun

Novartis Investigative Site, Harbin

Novartis Investigative Site, Arkhangelsk

Novartis Investigative Site, Beirut

Novartis Investigative Site, Singapore

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Pushkin Saint Petersburg

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Craiova

Novartis Investigative Site, Jaipur

Novartis Investigative Site, Hangzhou

Novartis Investigative Site, Cluj-Napoca

Novartis Investigative Site, Changsha

Novartis Investigative Site, Pune

Novartis Investigative Site, Wuhan

Novartis Investigative Site, Wuhan

Novartis Investigative Site, Hyderabad

Novartis Investigative Site, Omsk

Novartis Investigative Site, Kolkata

Novartis Investigative Site, Xi’an

Novartis Investigative Site, Kowloon

Novartis Investigative Site, Temuco

Novartis Investigative Site, Valledupar

Novartis Investigative Site, Santiago

Dana Farber Cancer Institute, Boston

Novartis Investigative Site, CABA

Novartis Investigative Site, Caba

Novartis Investigative Site, Linz

Novartis Investigative Site, Barretos

Novartis Investigative Site, São Paulo

Novartis Investigative Site, São Paulo

Novartis Investigative Site, Edmonton

Novartis Investigative Site, Brampton

Novartis Investigative Site, Toronto

Novartis Investigative Site, Ostrava

Novartis Investigative Site, Brno

Novartis Investigative Site, Brno

Novartis Investigative Site, Prague

Novartis Investigative Site, Oulu

Novartis Investigative Site, Dresden

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Halle

Novartis Investigative Site, Athens

Novartis Investigative Site, Athens

Novartis Investigative Site, Kowloon

Novartis Investigative Site, Reykjavik

Novartis Investigative Site, Hyderabad

Novartis Investigative Site, Gurgaon

Novartis Investigative Site, Perugia

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Sapporo

Novartis Investigative Site, Himeji

Novartis Investigative Site, Yokohama

Novartis Investigative Site, Sakai

Novartis Investigative Site, Sunto Gun

Novartis Investigative Site, Chuo Ku

Novartis Investigative Site, Ube

Novartis Investigative Site, Osaka

Novartis Investigative Site, Groningen

Novartis Investigative Site, Groningen

Novartis Investigative Site, Gliwice

Novartis Investigative Site, Poznan

Novartis Investigative Site, Tomaszw Mazowiecki

Novartis Investigative Site, Lisbon

Novartis Investigative Site, Porto

Novartis Investigative Site, Singapore

Novartis Investigative Site, Partizánske

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Badalona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Stockholm

Novartis Investigative Site, Ankara

Novartis Investigative Site, High Heaton

Novartis Investigative Site, London

Novartis Investigative Site, Manchester

Novartis Investigative Site, Plymouth